We have used DNaseI footprinting and gel mobility assays to analyze the upstream region of the human M-globin gene promoter. Four protein factors were found to bind this region. A non-erythroid factor present in the 0.4M KCl fraction of a heparin agarose column binds to the CAC box (-140). A ubiquitous octamer factor present in the 0.2M fraction binds to an ATGCAAT element (-175), but is competed out by the erythroid specific factor NF-E1 (in the 0.4M KC1 fraction), which binds a site (-186) immediately flanking the octamer. A novel factor binding to a stretch of 8A around -233, was identified in the 0.2M KC1 fraction. This factor is not present in HeLa nuclear extracts. To study the transcriptional importance of these protein binding sites we have used an "A-f-minilocus", similar to that described for the f-globin gene (1) in K562 cells. This provides evidence that the NF-E1 and CAC box in the -210 to -122 region of the _y-promoter are important for the efficient expression of the y-globin gene.
INTRODUCTION
The human Ay-globin gene is part of a multigene family that is expressed in a tissue and developmentally specific manner (for review see ref.
2). These genes are arranged in the transcriptional order 5 e Gy A_ 6-P-3', the embryonic e-gene being expressed only in the embryonic yolk sac, the foetal G.y. and Am-genes primarily in the foetal liver, and the adult 6- and P-genes in bone marrow. The minimal promoter of the A--globin gene contains a TATA box (-30) , two CAAT boxes (-85 and -110) and a CAC box (-140) (Fig. 1) . The duplication of the CAAT boxes has been shown not be essential for transcription, whereas a four fold reduction of transcription resulted from a deletion of the CAC box (3) . In addition as yet unidentified regulatory sequences are thought to be present between -259 and -137 (4) as well as an enhancer element at 400bp 3' to the polyadenylation site (5) .
Gene regulation is achieved through the action of trans-acting DNA binding factors and in many cases tissue-specific factors have been identified.
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sites in the promoter of the human P-globin gene (6) , as well as to four sites in its enhancer (7) , has been identified. The same factor is involved in the regulation of the chicken globin genes (8) and possibly the erythroid specific induction of non globin genes like the porphobilinogene deaminase gene (9) . The consensus sequence for the binding of this factor is A/C Py T/A ATC A/T Py and is found in the promoter of other erythroid cell specific genes, including the A"y-globin gene (Fig. 1 ). Several factors have been found to bind to the minimal promoter of the A7-yglobin gene. Three proteins bind to the CAAT region, the ubiquitous factor CP1 which binds preferentially to the proximal CAAT box (10), a vertebrate homologue of the sea urchin CAAT displacement factor (CDP), (10, 11) binding both CAAT boxes and their flanking sequences and the erythroid specific factor NF-E1 binding preferentially to the flanking sequences of the distal CAAT box (10, 12) .
Three other proteins have been shown to bind to the upstream region in K562 cells, two non erythroid factors, the ubiquitous octamer binding factor (ATGCAAAT, -175) and a protein around -280 and an erythroid specific factor the binding site of which, GATAG, appears to be part of the NF-E1 consensus sequence (12, 13) .
Using DNaseI footprinting, gel mobility shift and methylation interference assays, with nuclear factors from different cell types, we have characterized nuclease factors binding in the Atj-promoter upstream to the CAAT region. We have used a "A'y-minilocus" to study the effect of promoter deletions in this same region on the transcription of the Ak-gene in K562 cells. This is a human leukaemia cell line (14) which expresses the embryonic and foetal genes, but not the adult 0-globin gene (15) and provides a useful homologous system for studying the expression of the At gene. The "Ay-minilocus" is similar to that described for the 0-globin gene (1) (Fig. 1) . It contains the flanking regions of the human globin gene domain which has been shown to give rise to high copy number dependent expression of the human P-globin gene in the erythroid tissue of transgenic mice (1) or after transfection into erythroid cells in culture (16) . We show that the transcriptional level of the A-'-gene is reduced by step deletion of the sequence elements which bind two specific proteins, the erythroid specific factor NF-E1 and the ubiquitous CAC box protein.
RESULTS

Analysis of the upstream region of the A-Y-promoter by DNaseI footprinting
A fragment of the promoter region (-410 to -54) was used to label each (-140) . The footprint corresponding to the factor A from -254 to -284 was also present (13) . No strong footprints are observed in the CAAT region, but several hypersensitive sites can be seen due to the presence of the erythroid factor NF-E1, the CAAT box factor CP1 and the CAMT displacement factor CDP (10) .
As a first purification step we fractionated the K562 nuclear extract on a heparin agarose column and footprinted the coding strand with the 0.2M KC1 and 0.4M KCl fractions (Fig. 2b) . With the latter, the same footprints were obtained as with the crude extracts (Fig. 2a) To prevent both factors binding to the same oligonucleotide, the NF-E1 oligonucleotide included mutations in the ATGCAAAT octamer motif and the OCT nucleotide started in the middle of the NF-E1 motif (see Materials and Methods). Two other oligonucleotides covering both the NF-E1 and OCT regions from -195 to -163 (NF-E1/OCT1) and from -200 to -155 (NF-E1/OCT2) were also synthesized. As a control, each of these oligonucleotides were used as competitors against the footprint observed in the K562 crude nuclear extract and in the 0.2M KC1 fraction (Figs. 3a and 3b). With the crude extract, NF-E1, NF-E1/OCT1 and NF-E1/OCT2 totally eliminate the NF-E1/OCT footprint on both strands (-186, -175) (Fig. 3a) . OCT and surprisingly also AGC appear to partially compete the same footprints. AGC also totally competes the footprint at -270 (13). In the CAAT region some hypersensitive sites are also suppressed due to competition with NF-E1, NF-E1/OCT1 and NF-E1/OCT2, confirming the presence of an NF-E1 binding site at the CMT boxes (10) . These sites are only partially suppressed by competition with AGC the difference in size of the three oligonucleotides). The identity of the strong NF-E1 complex is confirmed by competition experiments (Fig. 4b) ; bands with similar intensity are seen with the strong NF-E1 binding sites -200, C and D oligonucleotides (Fig. 4a) , which also compete (data not shown), while the weak NF-E1 binding sites A and B fail to give effective competition (data not shown). The slow mobility complex formed with the NFEl/OCTI and NF-El/OCT2 probes, which has the same mobility as that observed with the known OCT complex on B or C (Fig. 4a) , is competed by B and C (data not shown) and an OCT probe (Fig. 4b) (Fig. 4a) . These can only be competed with the CAC oligonucleotide itself. The competition experiments (Fig. 4b) appear to confirm that the AGC oligonucleotide weakly binds the same protein as the OCT region in crude extracts. However, the footprint observed in the AGC region cannot be attributed to the octamer factor binding as it is not competed by the OCT oligonucleotide. We therefore also carried out gel shifts of the NF-E1, OCT and CAC oligonucleotides using the 0.2M KCl fraction of K562 crude extract and HeLa and B-cell crude extracts. Fig. 4c shows that the NF-El complex is erythroid specific, while the others are ubiquitous factors and only the octamer factors fractionate to the 0.2M KCl pool.
In order to study the apparent discrepancy between the footprint data and the AGC mobility shifts, two fragments, Hinfl-ApaI (-260, -210) and HinfI-NcoI (-260, -140), were used. With the crude extracts (Fig. 4d) , the HinfI-Apal fragment forms a main complex of very slow mobility also present with the HinfI-NcoI fragment. HinfI-Apal also contains the octamer and NFEl complexes in addition (Fig. 4d) . The large comlex is also present in HeLa and B-cell nucleic extracts (data not shown) and it is the same size as the larger complex obtained with a fragment covering the CAAT box region and the -200 region of the P-globin promoter (data not shown), identified as a vertebrate homologue of the CAAT displacement protein (CDP) (10, 5), although it is not efficiently competed by it. With the 0.2M KCl fraction however, the HinfI-ApaI fragment gave a new complex of slow mobility which is not related to CDP or the octamer protein, and is also badly competed by the AGC oligonucleotide (B2, Fig. 4f Fig. 5f . The unbound DNA from Fig. 5f is shown in lanes F. the octamer complex in addition (B1), which is competed by AGC and OCT oligonucleotides (Fig. 4f) . We did not detect the large complex (Bi) with a O.2M KCl fraction from MEL nucleic extracts, neither with a crude extract or a O.2M KCl fraction from HeLa cells (Fig. 4g) . A methylation interference assay of the each complex of the HinfI-NcoI fragment (G+A) confirms the binding of the smaller factor (B1) to the octamer consensus sequence (Fig.   5a ) and the corresponding contact sites are indicated in Fig. 6 . It also shows that the large factor (B2) binds to a series of A residues on the coding and noncoding strand of the AGC region (Figs. 5a, 6 ). The most 5' contact sites of these are outside the AGC oligonucleotide and this probably explains why it does not bind the large complex (B2), but it is able to compete this factor as shown in footprinting experiments (Fig. 3b) . From these results, we conclude that this region binds a factor (B2) which might be human or stage erythroid specific and which can be purified from NF-E1 by fractionation on a heparin-agarose column.
Methylation inteference was also done with the methylated (G + A) NF-E1/OCT2 oligonucleotide (Fig. 5b) . The binding s ites detected for NF-El on both strands were not only situated on its own consensus sequence, but also on the octamer consensus sequence further downstream (Fig. 6) . Conversely the G at -180 is also protected by the octamer factor and explains why it competes with NF-E1 for the binding of the -175 region under limiting probe conditions (footprints in Fig. 3a and data not shown) with NF-E1 binding preferentially.
Transcription analvsis of promoter deletions in a "'v-minilocus" in K562 cells
The construct we used to analyze the different protein binding regions contained the A-.yglobin gene with respectively 1.25kb of 5'-and 2.7kb of 3' flanking sequences (Fig. 1 ) and includes the 3' fragment that has been fection experiments, we introduced a HindIII linker in the NcoI restriction site present in the first exon (+59) of the A-fyglobin gene. This modification resulted in the addition of five nucleotides at this site and consequently to the corresponding mRNA, allowing us to distinguish the exogenous from the endogenous mRNA by primer extension analysis. The "extended" A-yglobin fragment was cloned in the minilocus (1) to provide high levels of expression in a copy number and position independent manner (16) . However, the initiation codon for the translation was lost in the linker modification and we would, therefore, expect a decrease in the level of the exogenous mRNA as a result of the loss of exogenous A--globin protein synthesis (26, 27) .
Deletions were introduced from the 5' end in the A-f-promoter by Bal3l digestion of an RsaI (-410), NcoI (+59, HindIII linkered) fragment cloned in pUC18 (Pharmacia). After Bal3l digestion the fragments were ClaI linkered and two of these deletions (-210 and -120) were used in this study. Two additional deletions were obtained from existing restriction sites HinfI (-260) and AvaII (-160) and were cloned in a modified pUC18 vector with a ClaI site in its linker. All deletions (-410, -260, -210, -160, -122) ( Fig.  1) were transferred in the Ay-construct (in Bluescript, Stratagene) as a
ClaI-NaeI fragment after removal of the unique NaeI site present in the vector (NaeI-SmaI deletion). Finally, the A-1-construct and the promoter deletion construct were transferred into the minilocus as ClaI-AspI fragments. The resulting constructs were linearized at a PvuI site in the cosmid pTCF (28) in which the minilocus was cloned (1). This cosmid also contains the Herpes Simplex Virus thymidine kinase (tk) gene promoter and polyA addition site driving the expression of a neo-resistance gene.
Transfection of K562 was done by electroporation (29) and for each construct three independent populations were selected and expanded in G418 containing medium.
Primer extension was used to analyze the exogenous and endogenous
A-"-globin mRNA by using a 22bp primer (+77 to +98). The conditions we used to separate the extension products results in three main bands corresponding to the expected size for the normal endogenous 'y-globin mRNA (Fig. 7 , labelled 'y end) and novel bands of slower mobility corresponding to the mRNA of the introduced genes (Fig. 7 , labelled -y ex. (Fig. 4a) are Spl and a factor similar to TEF2 (30, 31) . Of these two, the latter binds with a higher affinity and would be presumed to be the active species. Deletion of this binding site results in a decrease of transcription of the t-globin gene in agreement with the data obtained without the presence of the dominant control region (DCR) of the globin locus (2) . Whether this factor plays a mediating role between the upstream part of the promoter and the downstream CAAT/TATA box elements, similar to that proposed by SchOle et al., (32) or whether it acts as an independent auxiliary factor to the promoter is not clear from the present data. 2. In the -210 to -160 region, the ubiquitous octamer factor OTFI (24, 25) and the erythroid specific factor NF-E1 were found to compete for two overlapping binding sites. Of these two NF-E1 is more abundant (7), it binds with a higher affinity and must be the same as the erythroid factor decribed by Mantovani et al. (12) to bind to this region. The binding of OTF1 could only clearly be detected in non-erythroid extracts or after fractionation of the K562 nucleic extracts on a heparin-agarose column. Our expression data show that when this region is deleted from the promoter, there is a drop in transcriptional efficiency, which suggests that NF-E1 plays a positive regulatory role in this part of the promoter. Interestingly, NF-E1 has been proposed as the repressor of the -globin expression in adult cells where an increased binding of NF-E1 to the distal CAAT box would interfere with the binding of the CAAT box binding factor, CP1 and is based on the data obtained with -117 mutation of the Greek form of hereditary persistence of foetal haemoglobin (HPFH), which falls on a distal NF-E1 binding site (10, 12) . Thus, NF-E1 can act as a positive and possibly as a negative regulatory factor depending on the other factors with which it could interact, as it is the case for ElA protein (33) . It should be pointed out, however, that Mantovani et al. (12) have reported a separate erythroid factor to be involved in the -117 HPFH. A positive role for NF-E1 was also reported in the case of the P-globin gene where it was shown to exert its effect by interaction with CP1 (6) . From the single direction deletion data presented here, no such conclusion can be made. A number of HPFH mutations are associated with this region in both 'y-globin genes. Two mutations have been found at -198 and -196 (for review, see 34), just upstream of the NF-E1 binding site and one at -175 changing the T of the octamer sequence. These mutations could allow new factor(s) to bind and interact with NF-E1 or increase the binding of NF-E1 itself (10, 12 ) and result in a promoter which competes more effectively with the 0-globin gene in adult cells (16) . Indeed, the mutation at -175 would create a very similar situation as observed in the -200 region of the P-globin gene, two neighbouring NF-E1 sites, which creates a strong binding site for only one NF-E1 protein (6). 3. Lastly, in the -260 to -210 region, a new factor was identified with the 0.2M KCl fraction of the K562 nucleic extract. It was not present in HeLa cell nuclear extracts nor in the 0.2M KCl fraction from these latter. Methylation interference showed that it binds a stretch of 8A situated around -233. In this same region, the ubiquitous octamer factor exhibits a weak binding. It is presently not clear whether this second erythroid factor plays any functional role. No significant difference in transcription levels were observed when this binding site was deleted in our expression experiment. However, small effects may be lost in the reconstructed "minilocus" due to the change in distances between the DCR and the gene and the removal of the other globin genes and intergenic DNA and it remains a good possibility that this factor is important for the --globin gene promoter. Similarly no effect was observed for the deletion of the binding site for the A factor described by Mantovani et al. (13) .
MATERIALS AND METHODS
Oligonucleotides and primer
The olignucleotides used were: AGC:
CGATTAAAAAAAATTAAGCAGCAGTATCCTCTTGGGGAT; NF-E1:
CGATCCCCACACTATCTCAATGCACCAT;
OCT:
CGATTCTCAATGCAAATATCTGTCTGAAAT; NF-E1/OCT1: CGATCCACACTATCTCAAATGCAAATATCTGTCTGAAAAT: NF-E1/OCT2: CGATCTTCCCCACACTATCTCAATGCAAATATCTGTCTGAAACGGTCCCTAT; CAC: CGATCCCTGGCTAAACTCCACCATGGGTTGGCCAGCCAT.
The -200 oligonucleotide was as described by deBoer et al. (6) , the A, B, C and D oligonucleotides were as described by Wall et al., (7) . Adeno NF-1: TATACCTTATTTTGGATTGAAGCCAATATGATTGC; a-CMT: CTCCGCGCCAGCCAATGAGCGCCGCCC. The primer used for primer extension was: AGGCTTGTGATAGTAGCCTTGT.
AMV reverse transcriptase at 420C for lhr. 10gA of t-RNA was added as a carrier and the samples were precipitated in 100% ethanol. The products were resolved by electrophoresis in a 7% denaturing acrylamide gel of 90cm long and analyzed by autoradiography and densitometer scanning.
